PCI vs. CABG in patients aged under 50 years

Original title: Comparison of 30-Day and 5-Year Outcomes of Percutaneous Coronary Intervention Versus Coronary Bypass Grafting in Patients Aged ≤50 Years.  Reference: Fausto Biancari, et al. Am J Cardiology Article in Press.

 

Coronary artery bypass grafting (CABG) is associated with better evolution than percutaneous coronary intervention (PCI), mainly due to left main and multiple vessels re interventions. In ≤50 year old patients, results have not been thoroughly analyzed.

This retrospective analysis included 1617 patients receiving PCI and 592 receiving CABG for multiple vessels disease or left main lesions. Diabetes, renal failure, peripheral vascular disease, severe left main lesion, previous intervention and severe ventricular dysfunction occurred more often in the CABG group.

After propensity score matching, given the different baseline characteristics, 235 patients remained for final analysis. Immediate evolution, late mortality and freedom from cerebrovascular events at 5 years were similar in both groups. 

On the other hand, PCI patients presented lower freedom form revascularization and myocardial infarction. Among diabetics, global mortality was also similar in PCI and CABG groups but with greater chances of infarction, revascularization and stroke in the PCI group. 

STEMI patients receiving PCI presented a higher survival rate at 5 years, driven by its lower 30 day mortality rate (6% vs 1.5%; p=0.017). Freedom from combined events in this last group was similar. PCI was associated with repeat revascularization.

Conclusion

≤50 year patients have excellent immediate evolution with both PCI and CABG. At 5 years, PCI was associated with a significantly higher rate of infarction or repeat revascularization. 

Commentary

This analysis shows that evolution at 5 years with PCI or CABG is similar in terms or mortality. PCI is associated with higher rates of repeat revascularization and non-fatal AMI, as the large randomized studies show. In patients presenting with STEMI, PCI was superior to CABG in terms of mortality, which offers an advantage.

Carlos Fava

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...